In the context of pharmaceutical care, policy-makers repeatedly face the challenge of
balancing patient access to effective medicines with affordability and rising costs. With the …

Context Recent public outcry has highlighted the rising cost of prescription drugs worldwide,
which in several disease areas outpaces other health care expenditures and results in a …

Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

Background One target of the Sustainable Development Goals is to achieve" universal
health coverage, including financial risk protection, access to quality essential health‐care …

Strategies to achieve fairer prices for generic and biosimilar medicines Page 1 the bmj | BMJ
2020;368:l5444 | doi: 10.1136/bmj.l5444 1 Achieving FAir Pricing oF Medicines Strategies to …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Materials and methods This study followed an analytical method. Costs of various drugs
were obtained from the October-December 2019 edition of the Current Index of Medical …

Background Governance arrangements include changes in rules or processes that
determine authority and accountability for health policies, organisations, commercial …

Objective To determine medical needs, demographic characteristics and healthcare
utilisation patterns of the top 1% and top 2%–5% high-cost beneficiaries in the Netherlands …

Background Drug price transparency is defined as readily available information on the price
of pharmaceutical drugs to either authorities or consumers. Price transparency, together with …